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interactionsAbstract The compounds 5-(4-hydroxy-3-methoxy-phenyl)-3,7-dimethyl-5H-thiazolo[3,2-a]pyrim-
idine-2,6-dicarboxylic acid 2-ethyl ester 6-methyl ester (2a) and 3,7-dimethyl-5-naphthalen-1-yl-
5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid diethyl ester (2b) were synthesized by the base
catalyzed cyclocondensation of 3,4-dihydropyrimidine-2-thione with ethylacetoacetate. IR, 1H
NMR, 13C NMR spectra and elemental analysis were used to characterize these compounds. The
structures were determined by single crystal X-ray diffraction. The crystal structure is stabilized
by intermolecular O–H  N, C–H  O, C–H  p and p  p weak interactions.
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Dihydropyrimidines represent a heterocyclic system with
remarkable pharmacological efﬁciency and are described aspotent mimics of dihydropyridine calcium channel blockers
(Atwal et al., 1991; Rovnyak et al., 1992; Grover et al., 1995;
Kappe, 1993). It was established that calcium channel modula-
tion is dependent on the absolute conﬁguration at C5 chiral
carbon atom, whereby the orientation of the aryl group substi-
tuted to chiral carbon atom acts as a ‘‘molecular switch’’ be-
tween antagonist (aryl-group up) and agonist (aryl-group
down) activity (Kappe, 2000). In recent years, several biologi-
cal activities including antiviral, antitumor, antibacterial, and
anti-inﬂammatory activities has been reported for dihydropy-
rimidine derivatives (Atwal et al., 1990; Rovnyak et al.,
1995; Kappe et al., 1997).
Pyrimidine has been subjected to a large variety of struc-
tural modiﬁcations in order to synthesize derivatives (Singh
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Scheme 1 Synthesis of thiazolopyrimidine derivatives 2a and 2b.
Synthesis and characterization of 5-(4-hydroxy-3-methoxy-phenyl) 635et al., 2011) with different biological properties, among
which, thiazole ring fused to pyrimidine ring resulting in
thiazolopyrimidine is found to be more active (Ozair et al.,
2010a,b; Hayam et al., 2010). In order to prepare some
new fused thiazolopyrimidine derivatives, we employed the
cyclocondensation reaction of dihydropyrimidine with ethy-
lacetoacetate, bromine using triethylamine. The products
were characterized by IR, 1H NMR, 13C NMR spectra,
mass spectra and elemental analysis. Further, the structures
were veriﬁed by single crystal X-ray diffraction technique
and found to be in accordance with the spectroscopic char-
acterization. The present work describes the synthesis of two
thiazolopyrimidine derivatives and their crystal structures are
reported.Table 1 Crystal data and structure reﬁnement of compounds 2a an
Compound 2a
Empirical formula C20H22N2O6S
Formula weight 418.46
Temperature 296(2) K
Wavelength 0.71073 A˚
Crystal system, space group Monoclinic, P21
Unit cell dimensions
a 11.1859(9) A˚
b 16.9995(13) A˚
c 11.8892(9) A˚
b () 117.156(10)
Volume 2011.6(3) A˚3
z 4
Calculated density (mg/m3) 1.382
Absorption coeﬃcient (mm1) 0.201
F(000) 880
Crystal size (mm) 0.18 · 0.16 · 0.1
Theta range for data collection 2.37–27.00
Limiting indices 14 6 h 6 14
21 6 k 6 21
15 6 l 6 15
Reﬂections collected/unique 19,932/4383 [R(
Completeness to theta 27.00, 100.0%
Max. and min. transmission 0.9699 and 0.96
Reﬁnement method Full-matrix leas
Data/restraints/parameters 4383/0/268
Goodness-of-ﬁt on F2 0.980
Final R indices [I> 2r(I)] R1 = 0.0632
wR2 = 0.1641
R indices (all data) R1 = 0.1010
wR2 = 0.1840
Largest diﬀ. peak and hole (e A3) 1.049 and 0.242. Experimental
2.1. Materials
All reagents were obtained from commercial sources. Solvents
were dried and puriﬁed with known conventional methods.
2.2. Analytical methods
Melting points were determined in open capillaries using Guna
melting point apparatus and are uncorrected. The IR spectra
were recorded on Nicolet Impact 400D FT-IR spectrophotom-
eter using KBr pellets. 1H and 13C NMR were recorded on
Bruker 400-MHz FT NMR spectrometer in CDCl3 withd 2b.
2b
C24H24N2O4S
436.51
296(2) K
0.71073 A˚
/c Monoclinic, P21/c
10.719(3) A˚
10.504(3) A˚
19.163(5) A˚
95.918(5)
2146.0(9) A˚3
4
1.351
0.185
920
6 0.18 · 0.16 · 0.16
2.09–27.00
11 6 h 6 13
13 6 k 6 11
24 6 l 6 23
int) = 0.0557] 12,698/4658 [R(int) = 0.0495]
27.00, 99.4%
62 0.9710 and 0.9675
t squares on F2 Full-matrix least squares on F2
4658/0/284
1.040
R1 = 0.0586
wR2 = 0.1399
R1 = 0.0972
wR2 = 0.1723
5 0.489 and 0.304
636 H. Nagarajaiah, N.S. BegumTMS as internal standard. The reactions and purity of the
products were monitored by TLC silica gel plates. Mass spec-
tra were recorded on Finnigan MAT (Model MAT8200) spec-
trometer and elemental analyses were carried out using CHNS
Elimentar (Vario-micro cube).
2.3. Experimental procedure for the preparation of 5-(4-
hydroxy-3-methoxy-phenyl)-3,7-dimethyl-5H-thiazolo[3,2-
a]pyrimidine-2,6-dicarboxylic acid 2-ethyl ester 6-methyl ester
(2a) and its 6-ethyl ester naphthalene derivative (2b)
To a solution of ethylacetoacetate (0.72 mmol) in 2 ml of 1,2-
dichloroethane, bromine (0.72 mmol) was added slowly with
constant stirring until the solution turns colorless. To this
mixture compound 1 was added slowly followed by the addi-
tion of triethylamine (0.72 mmol) with constant stirring. The
reaction mixture was heated to 80 C with vigorous shaking
and heating was continued for 2 h. The solvent was removed
under reduced pressure and the residue was treated with aque-
ous sodium bicarbonate solution followed by extraction with
ethyl acetate and water. The ethyl acetate layer was dried overTable 2 Selected bond lengths (A˚) and bond angles () for 2a.
S(1)–C(8) 1.729(3)
S(1)–C(2) 1.747(3)
O(5)–C(16) 1.363(3)
O(5)–C(20) 1.424(4)
N(1)–C(8) 1.361(4)
N(1)–C(3) 1.400(3)
N(1)–C(5) 1.470(3)
C(15)–C(16) 1.385(4)
C(15)–C(14) 1.389(4)
C(2)–C(3) 1.340(4)
C(2)–C(11) 1.470(4)
O(1)–C(11) 1.338(4)
O(1)–C(12) 1.456(4)
C(3)–C(1) 1.479(4)
C(8)–N(2) 1.301(4)
C(14)–C(19) 1.385(4)
C(8)–S(1)–C(2) 90.41(14)
C(16)–O(5)–C(20) 118.1(2)
C(8)–N(1)–C(3) 115.0(2)
C(8)–N(1)–C(5) 118.4(2)
C(3)–N(1)–C(5) 123.2(2)
C(16)–C(15)–C(14) 121.1(3)
C(3)–C(2)–C(11) 127.4(3)
C(3)–C(2)–S(1) 112.7(2)
C(11)–C(2)–S(1) 120.0(2)
C(11)–O(1)–C(12) 114.9(3)
C(2)–C(3)–N(1) 111.5(2)
C(2)–C(3)–C(1) 129.7(3)
N(1)–C(3)–C(1) 118.7(3)
N(2)–C(8)–N(1) 126.3(3)
N(2)–C(8)–S(1) 123.3(2)
N(1)–C(8)–S(1) 110.4(2)
C(19)–C(14)–C(15) 118.4(3)
C(19)–C(14)–C(5) 119.0(2)
C(15)–C(14)–C(5) 122.6(2)
O(5)–C(16)–C(15) 125.1(3)
O(5)–C(16)–C(17) 115.0(2)
C(15)–C(16)–C(17) 119.9(3)
N(1)–C(5)–C(6) 107.2(2)anhydrous sodium sulfate. Pale yellow crystals were obtained
with good yield of about 80%.
2.4. Physical measurements
2.4.1. Preparation of 5-(4-hydroxy-3-methoxy-phenyl)-3,7-
dimethyl-5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid 2-
ethyl ester 6-methyl ester (2a)
Yield: 75%. m.p.: 114–115 C. IR (KBr mmax, cm1): 3330(OH),
2985(CH), 1712(C‚O), 1615(C‚C), 1506(C‚N). 1H NMR
(300 MHz, CDCl3) d ppm: 1.23–1.28 (s, 3H, alk-CH3), 2.38
(s, 3H, thiazole-CH3), 2.46 (s, 3H, allyl-CH3), 3.79 (s, 3H,
Ar-OCH3), 3.83 (s, 3H, –OCH3), 4.24–4.29 (q, J= 7.2 Hz,
2H, –OCH2), 6.09 (s, 1H, CH), 6.79–6.84 (m, 3H, ArH), 7.26
(s, 1H, Ar-OH). 13C NMR (CDCl3) d ppm: 12.64 (alk-CH3),
14.20 (thiazole-CH3), 23.49 (allyl-CH3), 51.10 (–CH), 55.19 (es-
ter-OCH3), 57.54 (Ar-OCH3), 61.49 (ester-OCH2), 102.42,
102.61–161.11 (Ar-H), 163.87 (ester C‚O), 166.97 (ester
C‚O). Mass (m/z): 418 M+, 401, 371, 387, 343 (base peak).
%CHNS found (calc): C 57.40 (57.21), H 5.30 (5.35), N 6.69
(6.38), S 7.66 (7.45).C(14)–C(5) 1.524(4)
C(16)–C(17) 1.393(4)
O(6)–C(17) 1.361(3)
C(5)–C(6) 1.522(4)
C(6)–C(7) 1.371(4)
N(2)–C(7) 1.395(4)
O(2)–C(11) 1.201(4)
C(17)–C(18) 1.376(4)
C(19)–C(18) 1.384(4)
C(6)–C(7) 1.354(5)
C(6)–C(9) 1.462(5)
C(7)–C(4) 1.492(4)
O(4)–C(9) 1.334(5)
O(4)–C(10) 1.488(6)
C(12)–C(13) 1.509(6)
C(9)–O(3) 1.201(5)
N(1)–C(5)–C(14) 110.5(2)
C(6)–C(5)–C(14) 112.5(2)
C(8)–N(2)–C(7) 115.9(3)
O(6)–C(17)–C(18) 118.6(3)
O(6)–C(17)–C(16) 122.6(3)
C(18)–C(17)–C(16) 118.8(3)
C(18)–C(19)–C(14) 120.5(3)
O(2)–C(11)–O(1) 123.8(3)
O(2)–C(11)–C(2) 125.1(3)
O(1)–C(11)–C(2) 111.0(3)
C(7)–C(6)–C(9) 122.8(3)
C(7)–C(6)–C(5) 120.3(3)
C(9)–C(6)–C(5) 116.8(3)
C(6)–C(7)–N(2) 122.1(3)
C(6)–C(7)–C(4) 125.6(3)
N(2)–C(7)–C(4) 112.4(3)
C(17)–C(18)–C(19) 121.1(3)
C(9)–O(4)–C(10) 120.4(4)
O(1)–C(12)–C(13) 107.6(3)
O(3)–C(9)–O(4) 121.2(4)
O(3)–C(9)–C(6) 126.1(4)
O(4)–C(9)–C(6) 112.6(3)
Synthesis and characterization of 5-(4-hydroxy-3-methoxy-phenyl) 6372.4.2. Preparation of 3,7-dimethyl-5-naphthalen-1-yl-5H-
thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid diethyl ester
(2b)
Yield: 82%. m.p.: 117–118 C. IR (KBr mmax, cm1):
2996(CH), 1712(C‚O), 1601(C‚C), 1496(C‚N). 1H NMR
(300 MHz, CDCl3) d ppm: 1.13–1.28 (t, J= 7.2 Hz, 3H, alk-
CH3), 1.25–1.30 (t, J= 7.2 Hz, 3H, alk-CH3), 2.33 (s, 3H, thi-
azole-CH3), 2.48 (s, 3H, allyl-CH3), 4.00–4.15 (q, J= 7.2 Hz,
2H, –OCH2), 4.21–4.26 (q, J= 7.2 Hz, 2H, –OCH2), 6.85 (s,
1H, CH), 7.42–8.45 (m, 7H, ArH). 13C NMR (CDCl3) d
ppm: 12.65 (alk-CH3), 14.22 (alk-CH3), 14.35 (thiazole-CH3),
23.59 (allyl-CH3), 55.24 (–CH), 57.24 (ester-OCH3), 60.04 (es-
ter-OCH3), 102.58–161.17 (Ar-H), 163.72 (ester C‚O), 166.51
(ester C‚O). Mass (m/z): 436 M+, 421, 407, 391, 363, 335,
309 (base peak). %CHNS found (calc): C 65.38 (65.49), H
5.25 (5.21), N 6.63 (6.77), S 7.59 (7.63).Table 3 Selected bond lengths (A˚) and bond angles () for 2b.
S(1)–C(8) 1.734(3)
S(1)–C(2) 1.752(3)
O(4)–C(9) 1.347(3)
O(4)–C(10) 1.451(3)
O(2)–C(12) 1.208(3)
O(1)–C(12) 1.345(3)
O(1)–C(13) 1.459(3)
O(3)–C(9) 1.211(3)
N(1)–C(8) 1.370(3)
N(1)–C(3) 1.404(3)
N(1)–C(5) 1.482(3)
N(2)–C(8) 1.308(3)
N(2)–C(7) 1.396(4)
C(23)–C(22) 1.426(4)
C(23)–C(24) 1.431(4)
C(16)–C(17) 1.398(4)
C(10)–C(11) 1.482(4)
C(8)–S(1)–C(2) 90.93(13)
C(9)–O(4)–C(10) 115.5(2)
C(12)–O(1)–C(13) 115.5(2)
C(8)–N(1)–C(3) 114.6(2)
C(8)–N(1)–C(5) 119.9(2)
C(3)–N(1)–C(5) 124.3(2)
C(8)–N(2)–C(7) 115.3(2)
C(22)–C(23)–C(24) 117.5(3)
C(22)–C(23)–C(15) 124.4(2)
C(24)–C(23)–C(15) 118.1(2)
C(19)–C(24)–C(18) 121.0(3)
C(19)–C(24)–C(23) 119.7(3)
C(18)–C(24)–C(23) 119.4(3)
N(1)–C(5)–C(6) 107.7(2)
N(1)–C(5)–C(15) 109.8(2)
C(6)–C(5)–C(15) 111.6(2)
C(3)–C(2)–C(12) 127.4(3)
C(3)–C(2)–S(1) 111.9(2)
C(12)–C(2)–S(1) 120.7(2)
C(2)–C(3)–N(1) 112.2(2)
C(2)–C(3)–C(1) 128.6(2)
N(1)–C(3)–C(1) 119.2(2)
C(7)–C(6)–C(9) 122.4(3)
C(7)–C(6)–C(5) 121.3(2)
C(9)–C(6)–C(5) 116.2(2)3. X-ray diffraction analysis
Pale yellow colored single crystals of compounds 2a and 2b
were obtained by slow evaporation of their solutions taken
in 1:1 mixture of ethyl acetate and methanol solvents. The
X-ray diffraction data, for both the compounds 2a and 2b were
collected on a Bruker Smart CCD Area Detector System using
MoKa (0.71073 A˚) radiation. The data were reduced using
SAINT-Plus (Bruker, 1998). The structures were solved by di-
rect methods using SHELXS97 (Sheldrick, 2008) and reﬁned
by difference Fourier syntheses using SHELXL97. The posi-
tions and anisotropic displacement parameters of all non-
hydrogen atoms were included in the full-matrix least-square
reﬁnement using SHELXL97 (Sheldrick, 2008) and the proce-
dures were carried until convergence was reached. Then the
hydrogen atoms were ﬁxed geometrically and were reﬁnedC(23)–C(15) 1.431(4)
C(24)–C(19) 1.413(4)
C(24)–C(18) 1.421(4)
C(5)–C(6) 1.523(4)
C(5)–C(15) 1.531(4)
C(2)–C(3) 1.348(4)
C(2)–C(12) 1.471(4)
C(3)–C(1) 1.487(4)
C(6)–C(7) 1.353(4)
C(6)–C(9) 1.471(4)
C(21)–C(22) 1.356(4)
C(21)–C(20) 1.411(4)
C(7)–C(4) 1.518(4)
C(18)–C(17) 1.348(4)
C(15)–C(16) 1.375(4)
C(13)–C(14) 1.434(5)
C(19)–C(20) 1.359(4)
C(22)–C(21)–C(20) 120.4(3)
C(6)–C(7)–N(2) 123.3(3)
C(6)–C(7)–C(4) 124.2(3)
N(2)–C(7)–C(4) 112.5(2)
C(17)–C(18)–C(24) 121.1(3)
C(16)–C(15)–C(23) 119.3(2)
C(16)–C(15)–C(5) 117.3(2)
C(23)–C(15)–C(5) 123.4(2)
O(2)–C(12)–O(1) 124.6(2)
O(2)–C(12)–C(2) 125.6(3)
O(1)–C(12)–C(2) 109.7(2)
C(21)–C(22)–C(23) 121.3(3)
C(15)–C(16)–C(17) 122.2(3)
C(18)–C(17)–C(16) 119.9(3)
C(20)–C(19)–C(24) 120.4(3)
O(3)–C(9)–O(4) 122.4(3)
O(3)–C(9)–C(6) 126.2(3)
O(4)–C(9)–C(6) 111.4(2)
O(4)–C(10)–C(11) 107.7(2)
C(19)–C(20)–C(21) 120.7(3)
C(14)–C(13)–O(1) 110.0(3)
N(2)–C(8)–N(1) 127.1(2)
N(2)–C(8)–S(1) 122.6(2)
N(1)–C(8)–S(1) 110.26(19)
Table 5 Non-bonded interactions and possible hydrogen
bonds (A˚, ) for compound 2b (D – donor; A – acceptor; H –
hydrogen).
D–H  A D–H H  A D  A D–H  A
C19–H19  N2i 0.930(3) 2.767(2) 3.641(4) 156
C10–H10B  O1ii 0.970(3) 2.799(2) 3.689(4) 153
C21–H21 . . .Ciiig1 0.930(3) 2.833(2) 3.652(4) 147
C1–H1C  Cgiv 0.960(3) 3.063(2) 3.963(4) 156
Symmetry code: (i) x  1/2, y+ 1/2, +z  1/2; (ii) x+ 2,
y+ 1, z; (iii) x  3/2, 5/2  y, z  1/2 and (iv) x  3/2, 5/2  y,
z  3/2.
Figure 1 Ortep view of compound 2a, showing 50% probability
Table 4 Non-bonded interactions and possible hydrogen bonds (A˚, ) for compound 2a (D – donor; A – acceptor; H – hydrogen).
D–H  A D–H H  A D  A D–H  A
O6–H6  N2i 0.820(3) 2.081(3) 2.882(4) 165
C20–H20C  O2ii 0.960(3) 2.521(2) 3.401(3) 152
C4–H4C  O2iii 0.960(4) 2.779(3) 3.615(6) 146
C20–H20A . . .Civg1 0.960(2) 2.681(3) 3.735(5) 143
Symmetry code: (i) x+ 1, y+ 1, z+ 1; (ii) x, y+ 1, z; (iii) x+ 1, y+ 1, z and (iv) 1  x, 1  y, 1z.
638 H. Nagarajaiah, N.S. Begumisotropically. Molecular diagrams were generated using OR-
TEP (Farrugia, 1999). The mean plane calculations were done
using the program PARST (Nardelli, 1983).
3.1. Compound (2a)
Intensity data were collected at 296 K in the x–/ scan mode. A
total of 19932 reﬂections were collected, resulting in 4383
[R(int) = 0.0557] independent reﬂections, of which the number
of reﬂections satisfying I> 2r(I) criteria were 2829. The R fac-
tor for observed data ﬁnally converged to R= 0.0632.
3.2. Compound (2b)
Intensity data were collected at 296 K for the compound in the
x–/ scan mode. A total of 12,698 reﬂections were collected,
resulting in 4658 [R(int) = 0.0495] independent reﬂections, of
which the number of reﬂections satisfying I> 2r(I) criteria
were 3053. These were treated as observed. The R factor after
ﬁnal convergence was 0.0586.
4. Results and discussion
4.1. Chemistry
Compounds 2(a–b) were synthesized by following the proce-
dure given in Scheme 1. The treatment of dihydropyrimidine
derivative (1) with equimolar quantities of ethyl acetoacetate,
molecular bromine and triethylamine under reﬂux for about
2 h, followed by the recrystallization from ethanol resulted in
the products 2(a–b) in 80% yield. The structures of 2(a–b) were
conﬁrmed by IR, 1H NMR and mass spectral techniques. IR
showed the absence of a sharp band due to NH stretching in
the frequency range of 3200–3400 cm1. 1H NMR spectra of
compounds 2(a–b) exhibited no peak corresponding to two
NH groups instead it showed additional triplet signal at
1.32 ppm (J= 7 Hz), corresponding to CH3 protons of the
ethoxy group at C2 carbon of the thiazolopyrimidine ring. A
quartet signal at 4.27 ppm (J= 7 Hz) due to CH2 at C2 car-
bon of the ethoxy group, conﬁrms the additional CH2 that
has appeared in the ﬁnal product and a singlet at 2.46 ppm cor-
responds to CH3 protons at C3 of the thiazolopyrimidine ring.
Also downﬁeld shift of the H5 proton from 5.5 to 6.0 ppm
marks the evidence for the formation of the expected product.
The structures were further conﬁrmed by recording the
mass spectra. The compound 2a gave the molecular ion peak
at m/z 418 (M+) and the compound 2b at m/z 436 (M+) cor-
responding to the molecular formula C20H22N2O6S for 2a and
C24H24N2O4S for 2b.4.2. Crystallography
Summary of crystallographic data and other structure reﬁne-
ment parameters of the compounds 2a and 2b are shown in Ta-
ble 1. The selected bond lengths and bond angles of all the
non-hydrogen atoms are given in Tables 2 and 3, respectively.
Tables 4 and 5 show the respective hydrogen bond interactions
in compounds 2a and 2b, respectively. The ORTEP view of the
molecules 2a and 2b with atom labeling (thermal ellipsoids
drawn at 50% probability) is shown in Figs. 1 and 2, respec-
tively. Fig. 3 shows the C–H  N intermolecular interaction
in compound 2a. Packing of molecules 2a and 2b in the crystal
structure is shown in Figs. 4 and 5, respectively. Fig. 6 shows
the p  p interaction in compound 2a.ellipsoids and the atom numbering scheme.
Figure 2 Ortep view of compound 2b, showing 50% probability
ellipsoids and the atom numbering scheme.
Figure 3 A unit cell packing of the compound 2a showing C–
H  N intermolecular interactions with dotted lines. H-atoms not
involved in hydrogen bonding have been excluded.
Figure 4 A unit cell packing of the compound 2a showing C–
H. . .O intermolecular interactions with dotted lines. H-atoms not
involved in hydrogen bonding have been excluded.
Synthesis and characterization of 5-(4-hydroxy-3-methoxy-phenyl) 639In compound 2a the substituted aryl group at C5 chiral car-
bon atom of the thiazolopyrimidine ring is positioned axially
(82.83) to the dihydropyrimidine ring. The ethyl carboxylate
and methyl groups are attached on the left side of the thiazol-
opyrimidine ring whereas the methyl carboxylate and the other
methyl group are on the other side of the ring. The methyl ester
and the ethyl ester groups adopt cis conformation with respect
to C6‚C7 and C2‚C3 bonds, respectively. The intramolecu-
lar hydrogen bond between carbonyl group of ester and methyl
substituent at C7 holds the ester group in cis orientation. The
methyl ester at C6 and the methyl group at C7 are projected
away from the plane of the thiazolopyrimidine ring. Maximum
perpendicularity between the two rings is achieved when there
are two methoxy substituents in benzene ring indicated by the
dihedral angle of 88.42 (Begum and Vasundhara, 2009). In 2a
the dihedral angle value is lowered to 82.83 when one of the
methoxy substituent at para position of the aryl ring is re-
placed by a hydroxyl group. Consequently, a conformational
ﬂexibility is induced in these molecules as the ester group as
well as the aryl rings can be freely rotated resulting in the sus-
ceptibility of the dihydropyrimidine ring to conformational
changes. In compound 2a, the C5 and N1 atoms of the pyrim-
idine ring are signiﬁcantly puckered, where the ring adopts a
conformation which is best described as an intermediate be-
tween a boat and screw boat form (Nagarajaiah and Begum,
2011; Mukesh et al., 2010). The plane calculation shows that
the atoms C5 and N1 deviate from the mean plane C8/N2/
C7/C6 constituting the ring by 0.1568 and 0.3003 A˚, respec-
tively. The ring puckering parameters (Cremer and Pople,
1975) for the pyrimidine ring are Q(2) = 0.2892(2) A˚,
u(2) = 12.93(7) and q= 67.51(5).
The molecular structure is stabilized by intermolecular O–
H  N and C–H  O interactions. The O–H  N intermolecu-
lar interaction results in cyclic dimers corresponding to graph
set (Bernstein et al., 1995) notation R22(20) (Fig. 2) along crys-
tallographic ‘b’ axis.
The C–H  O interaction forms two sets of centrosymmet-
ric head to head dimers with graph set motif R22(24) and
R22(18). The former results in a packing mode which resembles
that of a chair conformation and the latter generates pseudo
rectangular pattern. The molecular packing is further stabi-
lized by p–p stacking interactions between the thiazolopyrimi-
dine rings. The N1 and C8 atoms with symmetry equivalents
(1  x, 1  y, z) are disposed at a distance of 3.735(3) A˚.
In addition, p–ring interactions (Nagarajaiah et al., 2012) of
the type C–H  Cg (Cg being the centroid of the ring C14–
C19) are also observed in the crystal structure; details are given
in the Table 4.
The compound 2b has a naphthalene group at C5 chiral
carbon atom of the thiazolopyrimidine ring. There are two
ethyl ester groups attached at C6 and C2 positions and there
are two methyl groups at C3 and C7 oriented opposite to each
other. The two exocyclic ethyl ester groups, two methyl groups
and thiazolopyrimidine ring are in the same plane while the
naphthalene ring is positioned axially and almost bisecting
the pyrimidine ring making a dihedral angle of 87. The central
pyrimidine ring in compound 2b adopts a twist boat conforma-
tion due to the deviation of atoms C5 and C7 from the mean
plane N1/C8/N2/C6 constituting the ring by 0.3335 and
0.0467 A˚, respectively. The ring puckering parameters
(Cremer and Pople, 1975) for the pyrimidine ring are
Q(2) = 0.2064(2) A˚, u(2) = 4.36(6) and q= 63.31(6).
Figure 5 A molecular packing of the compound 2b showing C–H  O and C–H  N intermolecular interactions with dotted lines. H-
atoms not involved in hydrogen bonding have been excluded.
Figure 6 Compound 2a, showing p–p stacking interactions
between thiazolopyrimidine rings.
640 H. Nagarajaiah, N.S. BegumThe molecular structure is stabilized by strong intermolecu-
lar interactions, such as C9–H9  N2 resulting in one dimen-
sional zigzag chain along ‘c’ axis (Fig. 5), C10–H10B  O1
resulting in centrosymmetric dimers with graph set motifR22(24). Further stabilization is achieved by C–H  Cg and
p  p interactions (Table 5).
5. Conclusion
Present work describes the synthesis of diester of thiazolopyr-
imidine derivatives. The crystal structures of two thiazolopyr-
imidine derivatives have been determined. Insight into the self
assembly of these compounds shows varied types of non cova-
lent interactions that have great inﬂuence on crystal packing.
The crystal structure is stabilized by C–H  O and O–H  N
interactions. The C–H...O interaction bifurcates itself to form
two sets of centrosymmetric dimers.
6. Supplementary material
The CIF ﬁles are deposited at the Cambridge Crystallographic
Data Centre, The deposition number of compound 2a is
CCDC-841973 and deposition number of compound 2b is
CCDC-863685.Acknowledgments
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